Abstract: The techniques disclosed herein enable systems to translate three-dimensional experiences into user accessible experiences to improve accessibility for users with disabilities. Namely, the discussed system enables users with disabilities to create and personalize objects for use in the three-dimensional experience. This is accomplished by translating and grouping components from a three-dimensional space to form an intuitive and logical hierarchy. The grouped components are then organized into an accessible user interface which a user with disabilities can navigate using simplified inputs and assistive technologies. In this way, users with disabilities can be empowered to personalize their user experience and understand a three-dimensional space in a layered, well-defined format.

Abstract: Disclosed is a dual-receptacle carrier that is generally configured for attachment to a rollator or walker and that is configured to retain either a beverage or a mobile device, such as a cellular telephone. The device comprises a body, a base, and first and second opposing retention arm portions that are configured as a receptacle for a beverage. The first and second opposing retention arm portions and base include recesses that define a receptacle for an electronic device.

Abstract: Described are automated systems and methods for the handling and processing of items at material handling facility. The exemplary systems and methods can receive the items from various upstream processes and systems and can process and handle the items so that they can be provided to various downstream processes and systems. The exemplary systems and methods can provide modular systems and methods that can perform automated singulation, sortation, retrieval, and packing of items without any manual handling.

Abstract: The present disclosure provides methods and compositions for inhibiting corrosion of metallic surfaces and dissolving iron sulfide deposits in aqueous systems. A method may include adding a composition to the aqueous medium. The composition may include malic acid or a salt thereof. The composition may optionally include an organic solvent and/or a corrosion inhibitor.

Abstract: Immunoglobulin light chain proteins are used to generate synthetic fibrils in vitro. The fibrils are mixed with immunoglobulin light chain proteins from a biological sample. In either a direct binding assay, competition assay, or dilution-based competition assay, a signal is detected from the mixture. The intensity of the detectable signal relates to the level of binding between the immunoglobulin light chain proteins to the fibrils and can thus be used to identify amyloidogenic immunoglobulin light chain proteins in a biological sample of the subject and to assess amyloidogenic risk to a subject. For example, the signal intensities from the assays can be used in a comparison to one or more threshold (control) values derived from samples of known light chain types or in the absence of light chains. The comparisons permit identification of amyloidogenic proteins, assessment of amyloidogenic risk, and categorization of the subject into an appropriate “at risk” group.

Abstract: Immunoglobulin light chain proteins are used to generate synthetic fibrils in vitro. The fibrils are mixed with immunoglobulin light chain proteins from a biological sample. In either a direct binding assay, competition assay, or dilution-based competition assay, a signal is detected from the mixture. The intensity of the detectable signal relates to the level of binding between the immunoglobulin light chain proteins to the fibrils and can thus be used to identify amyloidogenic immunoglobulin light chain proteins in a biological sample of the subject and to assess amyloidogenic risk to a subject. For example, the signal intensities from the assays can be used in a comparison to one or more threshold (control) values derived from samples of known light chain types or in the absence of light chains. The comparisons permit identification of amyloidogenic proteins, assessment of amyloidogenic risk, and categorization of the subject into an appropriate “at risk” group.